Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chlorthalidone versus amlodipine for calcineurin inhibitor-induced hypertension
NL-OMON40718Withdrawn
- Sponsor
- Erasmus MC
- Start
- Mar 2014
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Randomised, open-label trial of chlorthalidone, amlodipine and cyclosporine in hypertension (HTN) (2 arms), sponsored by Erasmus MC. Primary endpoint: Change in average 24-hour systolic blood pressure. Planned start Mar 2014; status: withdrawn.
02
Drugs
chlorthalidoneamlodipinecyclosporine
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NL-OMON40718.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON40718.